SE403886B - Forfarande for framstellning av en farmaceutisk komposition for senkning av blodkolesterolnivan - Google Patents

Forfarande for framstellning av en farmaceutisk komposition for senkning av blodkolesterolnivan

Info

Publication number: SE403886B
Authority: SE; Sweden
Prior art keywords: preparing; procedure; pharmaceutical composition; cholesterol levels; lowering blood
Prior art date: 1972-10-06

Application number

SE7313618A

Other languages

English (en)

Swedish (sv)

Inventor

M N Cayen

D M Dvornik

Original Assignee

American Home Prod

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1972-10-06

Filing date

1973-10-05

Publication date

1978-09-11

1973-10-05 Application filed by American Home Prod filed Critical American Home Prod

1978-09-11 Publication of SE403886B publication Critical patent/SE403886B/xx

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Steroid Compounds (AREA)

SE7313618A 1972-10-06 1973-10-05 Forfarande for framstellning av en farmaceutisk komposition for senkning av blodkolesterolnivan SE403886B (sv)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
CA153,515A CA985172A (en)	1972-10-06	1972-10-06	Compositions and methods for reducing blood cholesterol

Publications (1)

Publication Number	Publication Date
SE403886B true SE403886B (sv)	1978-09-11

Family

ID=4094630

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SE7313618A SE403886B (sv)	1972-10-06	1973-10-05	Forfarande for framstellning av en farmaceutisk komposition for senkning av blodkolesterolnivan

Country Status (16)

Country	Link
US (1)	US3890438A (de)
AU (1)	AU477269B2 (de)
BE (1)	BE805634A (de)
CA (1)	CA985172A (de)
CS (1)	CS197387B1 (de)
DD (1)	DD106948A5 (de)
DE (1)	DE2348176A1 (de)
ES (1)	ES419355A1 (de)
FR (1)	FR2201893B1 (de)
GB (1)	GB1439625A (de)
HU (1)	HU169814B (de)
IE (1)	IE38274B1 (de)
IN (1)	IN138921B (de)
NL (1)	NL7313519A (de)
SE (1)	SE403886B (de)
ZA (1)	ZA737246B (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3838716A1 (de) *	1988-11-15	1990-05-17	Kanoldt Arzneimittel Gmbh	Arzneimittelzubereitung aus esterderivaten des hecogenins und dessen verwendung zur behandlung von benigner prostatahyperplasie
US6929807B1 (en) *	1996-08-09	2005-08-16	Mannatech, Inc.	Compositions of plant carbohydrates as dietary supplements
AU748138B2 (en) *	1998-03-26	2002-05-30	Phytopharm Plc.	Steroidal sapogenins and their derivatives for treating alzheimers disease
US20030118673A1 (en) *	1998-03-26	2003-06-26	Zongqin Xia	Smilagenin and anzurogenin-D for the treatment of alzheimer's disease
GB9923076D0 (en) *	1999-09-29	1999-12-01	Phytopharm Plc	Sapogenin derivatives and their use
GB2347676A (en) *	1999-03-08	2000-09-13	Phytopharm Plc	Screening method
GB9923078D0 (en) *	1999-09-29	1999-12-01	Phytopharm Plc	Sapogenin derivatives and their use
GB9923077D0 (en) *	1999-09-29	1999-12-01	Phytopharm Plc	Sapogenin derivatives and their use
GB0000228D0 (en) *	2000-01-06	2000-03-01	Phytopharm Plc	Fluoro substituted sapogenins and their use
GB0107822D0 (en) *	2001-03-28	2001-05-23	Phytopharm Plc	Sapogenin derivatives their synthesis and use methods based upon their use
WO2003022287A1 (fr) *	2001-08-24	2003-03-20	Jilin Tianyao Science And Technology Co. Ltd.	UTILISATION DE 3β-HYDROXY-5-SPIROSTENE POUR PREVENIR OU TRAITER DES MALADIES OU DES ETATS CARDIO-VASCULAIRES, INHIBER DES TUMEURS ET REDUIRE LES LIPIDES SANGUINS
US20050130948A1 (en) *	2002-03-27	2005-06-16	Daryl Rees	Therapeutic methods and uses of sapogenins and their derivatives
CN102727501A (zh) *	2002-03-27	2012-10-17	菲特法姆股份有限公司	皂角苷配基及其衍生物的用途
AU2003231427A1 (en) *	2002-04-15	2003-10-27	Chengdu Di'ao Pharmaceutical Group Co., Ltd.	Compounds and preparation methods of carboxylate and monoester succinate derivative of diosgenin
GB0409567D0 (en)	2004-04-28	2004-06-02	Phytopharm Plc	Chemical compounds
US20090209488A1 (en) *	2008-02-19	2009-08-20	Roger Wayne Brown	Compositions for the treatment of exercise induced asthma
US20090209486A1 (en) *	2008-02-19	2009-08-20	Roger Wayne Brown	Compositions of carbohydrates as dietary supplements
US20090209489A1 (en) *	2008-02-19	2009-08-20	Roger Wayne Brown	Compositions for the treatment of diabetis, system PH disorders, high blood pressure, and a cancer marker system
US20090208588A1 (en) *	2008-02-19	2009-08-20	Roger Wayne Brown	GERD carbohydrate compositions
EP2595621A1 (de)	2010-07-20	2013-05-29	Phytopharm PLC	Behandlung von l-dpa-, dopaminagonisten- und/oder dopaminverstärker-induzierten erkrankungen
FR3133158A1 (fr)	2022-03-04	2023-09-08	Psa Automobiles Sa	Procédé de gestion énergetique d’une prise d’alimentation d’accessoire dans un véhicule automobile à l’arrêt

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BE630211A (de) *	1962-03-28

1972
- 1972-10-06 CA CA153,515A patent/CA985172A/en not_active Expired
1973
- 1973-09-11 ZA ZA00737246A patent/ZA737246B/xx unknown
- 1973-09-17 US US398130A patent/US3890438A/en not_active Expired - Lifetime
- 1973-09-24 IE IE1698/73A patent/IE38274B1/xx unknown
- 1973-09-25 DE DE19732348176 patent/DE2348176A1/de active Pending
- 1973-10-01 IN IN2210/CAL/73A patent/IN138921B/en unknown
- 1973-10-02 NL NL7313519A patent/NL7313519A/xx not_active Application Discontinuation
- 1973-10-03 BE BE136318A patent/BE805634A/xx unknown
- 1973-10-04 HU HUAE394A patent/HU169814B/hu unknown
- 1973-10-05 ES ES419355A patent/ES419355A1/es not_active Expired
- 1973-10-05 CS CS736877A patent/CS197387B1/cs unknown
- 1973-10-05 FR FR7335748A patent/FR2201893B1/fr not_active Expired
- 1973-10-05 SE SE7313618A patent/SE403886B/xx unknown
- 1973-10-05 DD DD173898A patent/DD106948A5/xx unknown
- 1973-10-05 GB GB4656473A patent/GB1439625A/en not_active Expired
- 1973-10-08 AU AU61108/73A patent/AU477269B2/en not_active Expired

Also Published As

Publication number	Publication date
GB1439625A (en)	1976-06-16
ES419355A1 (es)	1976-03-01
IN138921B (de)	1976-04-17
FR2201893A1 (de)	1974-05-03
DD106948A5 (de)	1974-07-12
FR2201893B1 (de)	1977-09-09
IE38274L (en)	1974-04-06
ZA737246B (en)	1975-04-30
NL7313519A (de)	1974-04-09
DE2348176A1 (de)	1974-04-11
HU169814B (de)	1977-02-28
IE38274B1 (en)	1978-02-01
AU6110873A (en)	1975-04-10
BE805634A (fr)	1974-04-03
US3890438A (en)	1975-06-17
AU477269B2 (en)	1976-10-21
CS197387B1 (en)	1980-05-30
CA985172A (en)	1976-03-09

Similar Documents

Publication	Publication Date	Title
SE403886B (sv)	1978-09-11	Forfarande for framstellning av en farmaceutisk komposition for senkning av blodkolesterolnivan
SE395366B (sv)	1977-08-15	Forfarande for framstellning av porosa tabletter
NL7514012A (nl)	1976-06-04	Farmaceutische capsules.
IT1014737B (it)	1977-04-30	Bendaggio per pazienti laringecto mizzati
SE400771B (sv)	1978-04-10	Forfarande for framstellning av 3alfa-hydroxi- och 3alfa-hydroxi-19-norpregnaner
SE413246B (sv)	1980-05-12	Forfarande for framstellning av kolesteroloxidas
SE419339B (sv)	1981-07-27	Forfarande for framstellning av substituerade sulfonylacetamidocefalosporiner
SE397530B (sv)	1977-11-07	Forfarande for framstellning av 1-pyrazolylalkyl-4-arylpiperazinderivat
NO139124C (no)	1979-01-10	Fremgangsmaate for fremstilling av estere
SE7611202L (sv)	1976-10-08	Forfarande for framstellning av pyrazolodiazepinforeningar
SE423092B (sv)	1982-04-13	Forfarande for framstellning av vissa 13-tiaprostaglandiner
SE428692B (sv)	1983-07-18	Forfarande for framstellning av 7beta-amino-3-cefem-4-karboxylsyraforeningar
SE397201B (sv)	1977-10-24	Forfarande for framstellning av glukosisomeras fran en mikroorganism av slektet actionoplanes
SE395460B (sv)	1977-08-15	Forfarande for framstellning av 2beta,16beta-dipiperidino-5alfa-androstaner
NO139130C (no)	1979-01-10	Fremgangsmaate til fremstilling av 2-alkylamino-dihydropyridiner
IT1013028B (it)	1977-03-30	Procedimento per preparare maltitolo
SE387344B (sv)	1976-09-06	Forfarande for framstellning av pyrazin-4-oxidderivat
SE404525B (sv)	1978-10-09	Forfarande for framstellning av 4-aminometyl-cyklohexan-karboxylsyra-1
SE395705B (sv)	1977-08-22	Forfarande for framstellning av fusidinsyrakonjugat
SE385581B (sv)	1976-07-12	Forfarande for framstellning av foretrade n-metylolkarbamidforeningar
NO147644C (no)	1983-05-18	Fremgangsmaate for fremstilling av 6-amino-penicillansyre
IT999554B (it)	1976-03-10	Procedimento per preparare diacetossibutano
NO136750C (no)	1977-11-02	Fremgangsm}te for fremstilling av indanderivater
NO140185C (no)	1979-07-18	Fremgangsmaate til fremstilling av indolderivater
NO138886C (no)	1978-11-29	Fremgangsmaate ved fremstilling av oel